Investment in the DEZ
The Swiss pharmaceutical group Helsinn has announced a €6 million investment at its drug product supply centre located in the Dublin Enterprise Zone (DEZ).
Helsinn is a privately owned pharmaceutical group with an extensive portfolio of cancer care products.
The investment provides the company’s Irish subsidiary Helsinn Birex Pharmaceuticals Ltd (HBP) with the capability to apply unique serial numbers and tamper evidence features to drugs to ensure high quality products, safeguard its supply chain and comply with international regulatory requirements.
The company, whose headquarters are in Lugano, employs about 170 people at its facility in the DEZ in Mulhuddart.